title: Current state of the absorbable metallic (magnesium) stent.
abstract: BIOTRONIK's absorbable metal stent technology is based ona magnesium alloy that offers superior stent mechanics and biocompatibility. The first generation (AMS-1) showed promising results regarding mechanical properties as well as feasibility and safety in several human applications (150 cases). The second generation (AMS-2.1) shows improved scaffolding and efficacy in animals due to a more slowly degrading magnesium alloy and an optimised stent design. The preclinical results of the drug-eluting AMS-3 are encouraging and the clinical investigational program will resume in 2010.
authors.affiliation: Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, 110 Irving Street NW, Washington, DC 20010, USA. ron.waksman@medstar.net
authors.forename: Ron
authors.initials: R
authors.lastname: Waksman
mesh_terms: D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D000818:Animals; D003324:Coronary Artery Disease / Q000628:therapy*; D006801:Humans; D008274:Magnesium; D011474:Prosthesis Design; D015607:Stents; D016896:Treatment Outcome
chemical_list: D008274:Magnesium